Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 18.51 GBX -1.28% Market Closed
Market Cap: 76.3m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

Creo Medical Group PLC
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Creo Medical Group PLC
Cash from Financing Activities Peer Comparison

Comparables:
SN
LIVN
EKF
AGL
B
BELL

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Creo Medical Group PLC
LSE:CREO
Cash from Financing Activities
ÂŁ4.7m
CAGR 3-Years
720%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Cash from Financing Activities
$258m
CAGR 3-Years
-22%
CAGR 5-Years
21%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Cash from Financing Activities
$17m
CAGR 3-Years
N/A
CAGR 5-Years
-32%
CAGR 10-Years
N/A
EKF Diagnostics Holdings PLC
LSE:EKF
Cash from Financing Activities
-ÂŁ7.1m
CAGR 3-Years
-10%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Angle PLC
LSE:AGL
Cash from Financing Activities
ÂŁ7.8m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Belluscura PLC
LSE:BELL
Cash from Financing Activities
$12.5m
CAGR 3-Years
80%
CAGR 5-Years
29%
CAGR 10-Years
N/A

See Also

What is Creo Medical Group PLC's Cash from Financing Activities?
Cash from Financing Activities
4.7m GBP

Based on the financial report for Jun 30, 2024, Creo Medical Group PLC's Cash from Financing Activities amounts to 4.7m GBP.

What is Creo Medical Group PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-37%

Over the last year, the Cash from Financing Activities growth was -85%. The average annual Cash from Financing Activities growth rates for Creo Medical Group PLC have been 720% over the past three years , -37% over the past five years .

Back to Top